Auxly Cannabis Group Stock Cash And Equivalents
| CBWTF Stock | USD 0.03 0 3.70% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly OTC Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis otc stock.
Auxly |
Auxly Cannabis Group OTC Stock Cash And Equivalents Analysis
Auxly Cannabis' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Auxly Cannabis Cash And Equivalents | 20.53 M |
Most of Auxly Cannabis' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Auxly Cannabis Group has 20.53 M in Cash And Equivalents. This is 97.5% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.24% higher than that of the company.
Auxly Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auxly Cannabis' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics of similar companies.Auxly Cannabis is currently under evaluation in cash and equivalents category among its peers.
Auxly Fundamentals
| Return On Equity | -0.81 | |||
| Return On Asset | -0.0868 | |||
| Profit Margin | (1.34) % | |||
| Operating Margin | (0.52) % | |||
| Current Valuation | 146.85 M | |||
| Shares Outstanding | 913.01 M | |||
| Shares Owned By Insiders | 21.04 % | |||
| Shares Owned By Institutions | 3.18 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 0.16 X | |||
| Revenue | 83.83 M | |||
| Gross Profit | 19.29 M | |||
| EBITDA | (18.3 M) | |||
| Net Income | (33.74 M) | |||
| Cash And Equivalents | 20.53 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 151.36 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 2.58 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (49.63 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 558 | |||
| Beta | 0.77 | |||
| Market Capitalization | 14.61 M | |||
| Total Asset | 450.42 M | |||
| Net Asset | 450.42 M |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Auxly OTC Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.